Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
epidermolysis bullosa dystrophica
MeSH D016108 - epidermolysis bullosa dystrophica
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D004820:
Epidermolysis bullosa
1 Company
1 Drug
$
Success rate
D003095:
Collagen diseases
100 Companies
14 Drugs
$
Success rate
D016108:
Epidermolysis bullosa dystrophica
2 Companies
1 Drug
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
67
%
2/3
Phase 2
0
%
0/9
Phase 3
0
%
0/1
Approved:
0
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abeona Therapeutics
Prademagene zamikeracel
,
Bevifimod
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use